Table 2.
Patient characteristics | Mean RTL±SD | p-Value |
---|---|---|
Sex | 0.06 | |
Male | 0.96±0.18 | |
Female | 1.11±0.20 | |
Advanced T stage (T3–4) | 0.81 | |
Yes | 1.07±0.14 | |
No | 1.9±0.22 | |
Lymph node metastasis | 0.82 | |
Yes | 1.06±0.20 | |
No | 1.07±0.16 | |
Distant metastasis | 0.20 | |
Yes | 0.79 | |
No | 1.06±0.20 | |
Extrathyroidal extension | 0.68 | |
Yes | 1.05±0.13 | |
No | 1.09±0.22 | |
Lympho-vascular invasion | 0.46 | |
Yes | 1.03±0.22 | |
No | 1.11±0.21 | |
Multifocality | 0.72 | |
Yes | 1.07±0.22 | |
No | 1.09±0.20 | |
Disease recurrence | 0.57 | |
Yes | 1.17±0.06 | |
No | 1.08±0.21 | |
Presence of benign thyroid nodules | 0.60 | |
Yes | 1.10±0.21 | |
No | 1.07±0.21 | |
Thyroiditis | 0.53 | |
Yes | 1.05±0.17 | |
No | 1.10±0.22 | |
History of other cancers | 0.84 | |
Yes | 1.10±0.18 | |
No | 1.08±0.21 | |
Tobacco use | 0.70 | |
Yes | 1.13±0.15 | |
No | 1.10±0.21 | |
Radioactive iodine treatment | 0.20 | |
Yes | 1.05±0.20 | |
No | 1.13±0.21 |
RTL, relative telomere length.